PerkinElmer, Inc. announced that it has acquired Geospiza, Inc., a developer
of software systems for the management of genetic analysis and laboratory
workflows delivered through a Web-based secure cloud computing environment.
The acquisition of Geospiza supports PerkinElmer’s growing offerings in Next
Generation DNA Sequencing and Analysis Services, which enable researchers to
explore the genomic origins of disease more effectively, and help address
customers’ growing need to manage knowledge and drive scientific productivity.
The addition of Geospiza to PerkinElmer’s sequencing and analysis services will
deliver an end-to-end solution that provides scientists access to sequencing
services and analysis and visualization software, offered through cloud
“Genomic information is becoming increasingly important in understanding and
treating disease. Making sense of the unprecedented volumes of data generated
by next-generation sequencing and other biological measurements is critical to
improve the disease diagnosis process and drug discovery,” said Richard Begley,
PhD, president, Emerging Technologies, PerkinElmer.
He added, “The acquisition of Geospiza, along with existing software in our
various diagnostic businesses, gives PerkinElmer a strong platform for
offerings in nucleic acid testing.”